Peter Mørch Eriksen

Peter Mørch Eriksen has more than 20 years of experience within Medtech/life science both in Denmark and abroad. Peter Mørch Eriksen has been CEO of BioPorto A/S until 2021 and is now a board member of BioPorto A/S, Peter Mørch Eriksen has been the CEO of Sense A/S and before this, he held positions as Vice President of Medtronic in both the USA and Denmark. From these positions, Peter Mørch Eriksen brings extensive experience in creating growth, restructuring, and funding in technology-intensive and complex companies. Peter Mørch Eriksen has an accounting background supplemented with courses in management. In addition to being a Board member of BioPorto A/S, Peter Mørch Eriksen chairs the board of MTIC, is a board member at Nervex A/S, a member of Lund University Advisory Board, and Director of PMEconsult ApS. He also serves on the Medical Device and Diagnostics Advisory Committee of Cincinnati Children’s Hospital Medical Center in Ohio, US.